glp1 poly agonist peptides

Next Gen Weight Loss Drugs Are Coming for Ozempic’s Throne

Tue, 06/25/2024 - 12:15

The future of weight loss is fast approaching. At a recent scientific conference, drug companies showed off a variety of next-generation drugs for both obesity and type 2 diabetes. Some of these treatments might help people lose even more weight than current forerunners like Novo Nordisk’s semaglutide—the active…

Weight Loss, anti obesity medication, health medical pharma, glp 1 receptor agonist, semaglutide, robert gabbay, peptide therapeutics

Supplies of Wegovy and Other Weight Loss Drugs Can Now Be Tracked by Patients

Wed, 05/29/2024 - 19:09

Gizmodo

As Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and weight loss drugs, healthcare companies are introducing supply trackers to help patients navigate ongoing shortages.

eli lilly and company, anti obesity medication, health medical pharma, ro, Eli Lilly, patrik jonsson, glp1 poly agonist peptides

Weight Loss Drug Users Are Giving Up Their Vices

Tue, 04/23/2024 - 19:05

Gizmodo

It’s not only food CEOs who need to worry about their bottom lines thanks to in-demand weight loss drugs like Ozempic. Big Tobacco and Alcohol have reason to fret, too.

Morgan Stanley, anti obesity medication, tirzepatide, health medical pharma, glp 1 receptor agonist, semaglutide, Alcohol

Subscribe to glp1 poly agonist peptides